China’s rapidly changing regulatory landscape and intensifying anti-
corruption enforcement present new challenges for life sciences companies
looking to grow their business there. Please join us and our panel of China
life sciences experts for insights on how companies can devise winning
strategies and structure transactions in response to changing market
dynamics. Our panel will discuss how deals are now analyzed, common
themes among opportunities and challenges, and popular deal structures.
Confirmed speakers include:
Scott Barry, Managing Director, Co-head of China, Essex Woodlands
Matthieu Merlin, Vice President and Head of Business Development, Sanofi Asia
Rajesh Parekh, Director, McKinsey & Company
Prasanna Parthasarathy, Vice President, Dispensing Technologies, CareFusion
Ian Woo, Managing Director, Lazard Asia
Dong Wu, Head of Johnson & Johnson Innovation, Asia Pacific
Arthur Mok (Moderator), Partner, Ropes & Gray
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.